PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for a ...
Lack of toxicity data and poor physicochemical properties must be overcome. More than 25% of drugs on the market worldwide and candidates in the pharmaceutical pipeline were considered to be ...
OYE Therapeutics, a clinical-stage biopharmaceutical company advancing novel therapies for perioperative, emergency and acute ...
SHELTON, CT / ACCESSWIRE / November 15, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel ...
SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Eisai Co., Ltd. obtained marketing authorization approval in January 2024 from the ...
Application for Next Generation of Zohydro(R) ER to be Filed by October 2014 Zogenix, Inc. ZGNX +16.08% today announced an update on its development programs focused on the introduction of abuse ...
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable ...
Safety and efficacy data on the investigational subcutaneous formulation of ORENCIA in adults with moderate to severe rheumatoid arthritis to be presented at the American College of Rheumatology ...
Gain valuable insights into pharmaceutical development for sterile subcutaneous products with this exclusive webinar. Learn about critical development strategies and scenarios for initial launches and ...
The global formulation development outsourcing industry was estimated at $22.5 billion in 2021, and is anticipated to hit $51.9 billion by 2031, registering a CAGR of 9% from 2022 to 2031. The ...
The global formulation development outsourcing industry was estimated at $22.5 billion in 2021, and is anticipated to hit $51.9 billion by 2031, registering a CAGR of 9% from 2022 to 2031. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results